Description IGF-1 LR3 0.1mg Research Grade Peptide IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a synthetic analogue of endogenous IGF-1, engineered with an N-terminal 13 amino acid extension and an Arg3 substitution that significantly reduces insulin-like binding protein affinity, resulting in a markedly extended half-life compared to native IGF-1
Always discuss the best option for you with a healthcare professional, such as a Midi Health clinician
This compound is supplied strictly for research purposes, and none of this research constitutes clinical evidence of efficacy in human subjects
Research has shown that glutathione plays a critical role in phase II detoxification, a process where fat-soluble toxins are converted into water-soluble compounds that can be easily excreted from the body
AbbVie finally agrees a Most-Favoured Nation pricing deal with the US administration, with a $100 billion investment promise attached
This mechanism may be particularly relevant for patients who had significant insulin resistance before starting GLP-1 therapy
